SGLT2 Inhibitors in Type 2 Diabetes Mellitus

被引：3
|
作者：
Ferrannini, Giulia [1 ]
Savarese, Gianluigi [1 ,2 ]
Cosentino, Francesco [1 ,2 ]
机构：
[1] Karolinska Inst, Dept Med, Div Cardiol, Norrbacka S1 02, SE-17177 Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Cardiol, Heart Vasc & Neuro Theme, Anna Stecksens Gata 41, S-17164 Solna, Sweden
来源：
HEART FAILURE CLINICS | 2022年 / 18卷 / 04期
关键词：
Sodium-glucose cotransporter 2 inhibitors; Type; 2; diabetes; Cardiovascular outcomes; Heart failure; COTRANSPORTER; 2; INHIBITORS; HEART-FAILURE; CARDIOVASCULAR RISK; GLUCOSE TRANSPORTERS; MORTALITY INSIGHTS; NA+/H+ EXCHANGER; BLOOD-PRESSURE; DOUBLE-BLIND; EMPAGLIFLOZIN; DEATH;
D O I：
10.1016/j.hfc.2022.03.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：551 / 559
页数：9
相关论文
共 50 条
  • [21] SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases
    Christoph Wanner
    Nikolaus Marx
    [J]. Diabetologia, 2018, 61 : 2134 - 2139
  • [22] SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus
    Ghosh, Raktim Kumar
    Ghosh, Samhati Mondal
    Chawla, Shalini
    Jasdanwala, Sarfaraz Abdeli
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (04): : 457 - 463
  • [23] SGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitus
    Misra, Monika
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2013, 65 (03) : 317 - 327
  • [24] Predictors of weight reduction effectiveness of SGLT2 inhibitors in diabetes mellitus type 2 patients
    Danpanichkul, Pojsakorn
    Manosroi, Worapaka
    Nilsirisuk, Tharadon
    Tosukhowong, Theetouch
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [25] Intensification of Human Insulin Therapy with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Dzida, Grzegorz J.
    Gajda, Piotr
    Masierek, Malgorzata
    [J]. DIABETES, 2024, 73
  • [26] SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases
    Wanner, Christoph
    Marx, Nikolaus
    [J]. DIABETOLOGIA, 2018, 61 (10) : 2134 - 2139
  • [27] The role of SGLT2 inhibitors in managing type 2 diabetes
    Tat, Velen
    Forest, Christopher P.
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2018, 31 (06): : 35 - 40
  • [28] SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes?
    Saisho, Yoshifumi
    [J]. DISEASES, 2020, 8 (02)
  • [29] Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes
    Muskiet, Marcel H. A.
    van Bommel, Erik J. M.
    van Raalte, Daniel H.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (03): : 188 - 189
  • [30] The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
    Vallon, Volker
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 66, 2015, 66 : 255 - 270
12345